RRM1 and malignant pleural mesothelioma: Higher RRM1 expression was associated with shorter survival in non-small cell lung cancer patients treated with gemcitabine-based therapies24, but with better outcomes in malignant pleural mesothelioma patients treated using different chemotherapy regimen25.